Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neotherapuetics possibly has a breakthrough drug - NEOT -- Ignore unavailable to you. Want to Upgrade?

To: Marty who wrote (101)	7/24/2000 10:52:29 AM
From: StockDoc	Respond to of 204

Fundamental questions. I'm new here and looking for reliable info. The idea sounds good. The compounds might work. Is NEOT a family business? Is their medical team professionally competent (strong scientific background, successful clinical trials providing clear answers on toxicity, dose, primary end-point for Phase III) or work-for-Pharma-money and jump-in-time type docs? Any info on this? Their CEO seemed to jump into solid conclusions on efficacy in their recent news release (he's a Ph.D. though and probably have no idea) Any clinical data (with p values) published? Thanks